Home > Resources > Whitepapers > Pharmaceutical & Biotechnology Perspectives in Liquid Process Analytics

Pharmaceutical & Biotechnology Perspectives in Liquid Process Analytics

March 5, 2018

Analytical measurements are going digital. The advantages offered by the latest, cutting-edge in-line sensors and transmitters, such as greater process quality and yield, reduced sensor maintenance, and simplified regulatory compliance, are hard to ignore. ISM, METTLER TOLEDOʼs digital sensor technology, has transformed the way analytical sensors are handled and maintained from first installation to end of life. ISM offers a level of performance and convenience that is not available with other systems.

Spotlight

Vanguard Healthcare Services, LLC

Vanguard Healthcare Services, LLC manages skilled-nursing facilities in four states - Florida, Mississippi, Tennessee and West Virginia. Our goal is to become the best patient-care focused company in the long-term care industry.

OTHER WHITEPAPERS

Producing therapeutic peptides using biotechnology

whitePaper | October 20, 2022

We began the project by working to the design of a recombinant bacterial strain selection of a strain capable of producing high concentrations of peptides.

Asia Pacific Leads The Way In Cell & Gene Therapy Trials

whitePaper | December 16, 2022

Cell and gene therapies (CGTs) are continuing to gain momentum in life sciences globally. However, Asia Pacific (APAC) has demonstrated the most growth in CGT developers of any other region, with a rise of 10% in H1 2022 compared to 2021.1

U.S. Biopharma Expansions to Europe: Ensuring Successful Build-Out & Market Access

whitePaper | May 24, 2023

The Greater Zurich Area Ltd (GZA), Apellis, and Korn Ferry co-hosted a virtual roundtable for a select group of biopharma leaders interested in expanding their operations into Europe. The panel brought together European launch specialists, talent experts, and Swiss government officials to cover critical questions and guiding principles necessary for a successful European launch, as well as insider knowledge of how to best navigate the regulatory environment.

Accelerating Global Access to Gene Therapies: Case Studies from Lowand Middle-Income Countries

whitePaper | October 18, 2022

This document is published by the World Economic Forum as a contribution to a project, insight area or interaction. The findings, interpretations and conclusions expressed herein are a result

Next Generation Therapies and related Life Sciences topics

whitePaper | January 16, 2022

All gene therapies insert engineered DNA/RNA into living cells to make or modify new proteins

2022 Biosimilars Report: The U.S. Journey and Path Ahead

whitePaper | June 8, 2022

Cardinal Health is fortunate to sit at the crossroads of the United States (U.S.) healthcare system, engaging with stakeholders from across the industry including healthcare